StonvexLoading…
StonvexStonvexStonvexCore line items from UPXI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $15.81M | $26.00M | $36.44M | $23.07M |
Operating Income | $-12.50M | $-22.46M | $-12.28M | $-6.49M |
Net Income | $-13.68M | $-23.66M | $-17.49M | $-2.05M |
EPS (Diluted) | $-1.73 | $-23.03 | $-18.94 | $-0.43 |
Total Assets | $123.81M | $23.51M | $63.80M | $48.49M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $2.98M | $661.41K | $4.49M | $7.15M |
Free Cash Flow OCF − CapEx | $-8.81M | $-1.03M | $-734.89K | $-5.63M |
Shares Outstanding | 38.27M | 1.05M | 1.05M | 16.71M |